The impact of giving to MSK

At Memorial Sloan Kettering Cancer Center (MSK), donor contributions fuel a pioneering movement against cancer. We are making breakthroughs in understanding, diagnosing, and treating the disease. Thanks to donor support, we’re reshaping the landscape of cancer care, providing hope for a future without cancer.

Two MSK physician-scientists wearing white lab coats smile while walking side by side.

Why donate to cancer research, care, and education at MSK?

Paradigm-shifting research

Donations to MSK provide integral funding for world-class, original cancer research, allowing us to make lifesaving discoveries.

Nearly 2,000 clinical trials are underway at MSK at any given time.

47% of MSK clinical trials are investigator-initiated — making it possible for promising new treatments to get to people who need them, faster.

MSK and our dedicated research arm, the Sloan Kettering Institute, are home to 23 collaborative research centers that bring laboratory scientists and clinical experts together to spark innovation.

Innovative treatments and compassionate care

With your help, MSK can continue elevating cancer care worldwide, making sure people do better on their own terms.

Five-year survival rates for all types of cancer are an average of 50% higher at MSK than for the Commission on Cancer, a consortium of cancer organizations.

MSK was ranked as the No. 1 hospital for oncology in the world according to Newsweek’s World’s Best Specialized Hospitals 2026 list.

U.S. News & World Report has recognized MSK as one of the top two cancer hospitals in the nation for more than 35 consecutive years.

Educating the next generation of leaders

Donor-supported research grants, fellowships, and education programs allow future leaders to become experts in their field, so they can go on to treat patients and teach caregivers around the world.

More than 2,300 residents, fellows, and PhD candidates train at MSK each year.

MSK offers or participates in 12 PhD programs, including a first-of-its-kind Cancer Engineering PhD program at the Gerstner Sloan Kettering Graduate School of Biomedical Sciences.

Video: MSK donors fuel hope

Anne’s rare cancer vanished after she joined a clinical trial at MSK. Watch as Anne shares her story and see how your support fuels breakthroughs that save lives.

Your donations do a world of good

Philanthropy gives MSK physicians and scientists the support they need to find new cures for cancer and share breakthroughs with the world.

50%

of MSK published research

involves an international collaboration

1,200

Cities in 80 countries

where researchers are partnering with MSK on early detection

2,300+

Cancer experts

from around the world training to become the next generation of leaders

Together, we can achieve so much more

Make a donation

The difference you’re making

Our community drives progress for people facing cancer worldwide. With donor support, MSK continues to discover new ways to treat people with cancer and also prevent, detect, and cure all forms of the disease.

An MSK scientist looks into a microscope in a laboratory.

Discoveries made by MSK scientists — including identifying a new form of lung cancer and unlocking the secrets of metastasis — are transforming our understanding of the disease and paving the way for even more new therapies.

Top research advances

Closeup of gloved hands arranging test tubes in a laboratory at MSK.

From innovative surgical techniques and diagnostic tools to a range of new FDA-approved drugs, MSK is pioneering advances in cancer treatment that bring hope to people worldwide — all thanks to our generous donor community.

Top treatment advances

MSK patient and jazz musician Michael Wolff, dressed in black and standing, smiles in conversation.

MSK is a leader in precision oncology thanks to donors. 'Newsweek' showcased this excellence via the inspiring story of Michael Wolff, whose MSK physician identified the genetic cause of his rare cancer and found a drug to stop it.

Two MSK physicians in lab coats stand looking at a computer monitor together.

Thanks to philanthropy, MSK’s leadership in treating young people with cancer is unsurpassed. Donor support has been vital to the world-renowned work of Andrea Cercek, MD, featured in 'Time' magazine this year.

MSK in 'Time' magazine

At MSK, philanthropy accelerates breakthroughs like leading-edge imaging techniques and AI-driven methods that are paving the way for groundbreaking drug and vaccine design.